John Cox, Director at REPLIGEN CORP (RGEN), sold 53,472 shares at $96.45 ($5.1M) on 2020-03-18, disclosed to the SEC on 2020-03-20.
Open-market sale of $5.1M RGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.13 | 24,533 | $2.3M | 45.8% |
| 2 | $95.13 | 24,533 | $2.3M | 45.8% |
| 3 | $96.45 | 1,187 | $114K | 2.2% |
| 4 | $96.45 | 1,187 | $114K | 2.2% |
| 5 | $97.17 | 1,016 | $99K | 1.9% |
| 6 | $97.17 | 1,016 |
| $99K |
| 1.9% |
| Total | $95.27 avg | 53,472 | $5.1M | 100% |
| Filing → |
| DYN | SELL | 2026-06-17 | $49K | — | Filing → |
| DYN | SELL | 2026-05-14 | $61K | — | Filing → |
| DYN | SELL | 2026-03-06 | $41K | — | Filing → |